Buy Stocks Easy | About Us

September 19, 2021

ITCI

Buy Intra-Cellular Therapies Inc. Stock (symbol: ITCI) Easy Online

Company Name: Intra-Cellular Therapies Inc.

Symbol: ITCI

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2014

ITCI Current Share Price

Today's ITCI ( Intra-Cellular Therapies Inc. ) opening price: $12.5700

Yesterday's ITCI ( Intra-Cellular Therapies Inc. ) closing price: $12.4500

Intra-Cellular Therapies Inc. Stock ( symbol: ITCI ) Price Chart since IPO (2014):

12 Months Intra-Cellular Therapies Inc. Stock ( symbol: ITCI ) Price Chart

Popular Questions about Intra-Cellular Therapies Inc. Public Stock ( ITCI )

A: Intra-Cellular Therapies Inc. stock symbol (also called stock or share ticker) is ITCI

A: Intra-Cellular Therapies Inc. IPO (Initial Public Offering) took place on 2014

A: Intra-Cellular Therapies Inc.'s stock (ITCI symbol) price at ther IPO (initial Public Offering) was $12.5700

Q: Is ITCI stock worth buying at the moment?

A: If you were looking for a long-term investment portfolio and had bought the 'Intra-Cellular Therapies Inc. stock (symbol: ITCI) at the beginning of 2019, at the opening share price of $12.0400, with a minimum of $200, by now your shares would be worth $3522 and your profit would be $3322 - SHOW ONLY IF PROFIT.

Buy Intra-Cellular Therapies Inc. Stock Easy Online

Intra-Cellular Therapies Inc. Stock Ticker Price Chart since IPO:

Intra-Cellular Therapies Inc. Stock Price Yesterday

Intra-Cellular Therapies Inc. Stock Price – Last Week

Intra-Cellular Therapies Inc. Stock Price – Last Month

Intra-Cellular Therapies Inc. Stock Value Chart – 12 Months

Rate this post

Latest Stock News:

https://www.fool.com/investing/2019/12/16/3-biotech-stocks-with-big-incoming-catalysts.aspx

3 Biotech Stocks With Big Incoming Catalysts

Investors expect stock-moving news from all of these drugmakers bef...

http://www.globenewswire.com/news-release/2019/12/12/1959794/0/en/Intra-Cellular-Therapies-Highlights-Lumateperone-Presentations-at-the-58th-Annual-Meeting-of-the-American-College-of-Neuropsychopharmacology.html

Intra-Cellular Therapies Highlights Lumateperone Presentations at the 58th Annual Meeting of the American College of Neuropsychopharmacology

Bipolar depression: Study 404, A Phase 3 Clinical Trial of lumatep...

http://www.zacks.com/stock/news/665354/intra-cellular-therapies-itci-in-focus-stock-moves-61-higher

Intra-Cellular Therapies (ITCI) in Focus: Stock Moves 6.1% Higher

Intra-Cellular Therapies (ITCI) saw a big move last session, as its...

https://www.fool.com/investing/2019/12/07/4-fda-dates-biotech-investors-should-circle-in-dec.aspx

4 FDA Dates Biotech Investors Should Circle in December

FDA announcements can make or break a stock. These four events are ...

https://www.fool.com/investing/2019/12/07/biotechs-year-end-to-do-list.aspx

Biotech’s Year-End To-Do List

The remaining weeks of December are chock-full of clinical trial re...

https://seekingalpha.com/article/4310670-intra-cellular-side-of-rainbow

Intra-Cellular: The Other Side Of The Rainbow

Intra-Cellular: The Other Side Of The Rainbow

http://www.globenewswire.com/news-release/2019/12/04/1956121/0/en/Intra-Cellular-Therapies-to-Present-Data-on-Lumateperone-and-ITI-333-at-the-58th-Annual-Meeting-of-the-American-College-of-Neuropsychopharmacology.html

Intra-Cellular Therapies to Present Data on Lumateperone and ITI-333 at the 58th Annual Meeting of the American College of Neuropsychopharmacology

NEW YORK, Dec. 04, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therap...

http://www.zacks.com/stock/news/627312/options-traders-expect-huge-moves-in-intra-cellular-therapies-itci-stock

Options Traders Expect Huge Moves in Intra-Cellular Therapies (ITCI) Stock

Investors need to pay close attention to Intra-Cellular Therapies (...

http://www.zacks.com/commentary/614323/top-ranked-momentum-stocks-to-buy-for-november-11th

Top Ranked Momentum Stocks to Buy for November 11th

Top Ranked Momentum Stocks to Buy for November 11th

All right reserved Buy Stocks Easy , 2019.